Amgen to buy cancer drug developer Five Prime Therapeutics for $1.9 billion

March 4 (Reuters) – Drugmaker Amgen Inc will acquire cancer drug developer Five Prime Therapeutics for about $1.9 billion, the companies said on Thursday. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur)

Source


More from: | Category: M&A News